- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06963944
- Original Trial
Physiological Dead Space and Intensive Care Mortality in Mechanically Ventilated Patients (IRIS-MAP)
Investigation of the Relationship Between Physiological Dead Space and Intensive Care Unit Mortality in Mechanically Ventilated Adult Patients: A Prospective Observational Study
This study investigates the relationship between physiological dead space and clinical outcomes, specifically mortality and discharge status, in adult patients receiving invasive mechanical ventilation in the intensive care unit (ICU). Physiological dead space refers to ventilated but non-perfused regions of the lungs and can be quantified using the Enghoff-modified Bohr equation based on capnographic and arterial CO₂ measurements.
While volumetric capnography is a valuable tool in anesthesiology and perioperative care, its use in ICU settings remains limited. By continuously monitoring physiological dead space at the bedside, this study aims to provide real-time insight into ventilation-perfusion mismatch and assess its prognostic significance in critically ill patients.
Study Overview
Status
Detailed Description
Physiological dead space is defined as the portion of tidal volume that does not participate in effective gas exchange. It includes both anatomical and alveolar components and is a dynamic marker influenced by pulmonary perfusion, airway patency, ventilation settings, and lung pathology. In critically ill patients, particularly those receiving invasive mechanical ventilation, monitoring dead space may provide valuable insight into disease severity, ventilation-perfusion mismatch, and the adequacy of mechanical ventilation.
While capnography is routinely used in operating rooms and during anesthesia management, its role in intensive care units (ICUs) remains underutilized. Volumetric capnography offers a non-invasive, continuous method for assessing expired CO₂ and evaluating respiratory physiology in real time. Through the Enghoff-modified Bohr equation, physiological dead space can be calculated using the difference between arterial and end-tidal CO₂ (DS = (PaCO₂ - EtCO₂)/PaCO₂). This approach allows clinicians to quantify dead space without requiring invasive or complex instrumentation beyond standard ICU monitoring tools.
Previous research has identified an association between elevated dead space ventilation and increased mortality in conditions such as acute respiratory distress syndrome (ARDS), sepsis, and severe pneumonia. However, the utility of this parameter as a bedside prognostic tool in routine ICU practice remains limited by the lack of prospective validation and standardized monitoring protocols. Moreover, static measurements at a single time point may be insufficient to capture the clinical trajectory of critically ill patients, whereas trend analysis could provide more meaningful prognostic information.
This prospective observational study is designed to evaluate the relationship between physiological dead space and clinical outcomes, specifically ICU mortality and discharge disposition, in adult patients undergoing invasive mechanical ventilation. The study is conducted in a tertiary university hospital ICU and includes adult patients (≥18 years) who meet predefined inclusion criteria. Exclusion criteria are applied to eliminate potential confounders such as patients with noninvasive ventilation, pediatric cases, or those with significant technical limitations affecting capnographic measurements.
Data collection includes demographic characteristics, comorbidities, primary ICU admission diagnoses, ventilator parameters (tidal volume, PEEP, respiratory rate, minute ventilation, driving pressure), arterial blood gas values (PaO₂/FiO₂, PaCO₂), sedation level (RASS), vasoactive medication use, and daily volumetric capnography measurements (EtCO₂). Dead space values are recorded using standardized measurement windows, and time-series analysis is performed based on repeated observations during the ICU stay. The mode of discharge (survival, death, or transfer) is also documented.
The study aims to determine whether physiological dead space at ICU admission and its progression over time can serve as a reliable predictor of outcome. Additionally, it explores the feasibility of incorporating capnography-based dead space assessment into routine ICU monitoring as a noninvasive tool for early prognostication and ventilation optimization. Findings from this study may support broader use of volumetric capnography in intensive care medicine and contribute to individualized patient care strategies.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Trabzon, Turkey, 61080
- Karadeniz Technical University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Admitted to the intensive care unit
- Receiving invasive mechanical ventilation
- Monitored with volumetric capnography and arterial blood gas analysis
- Informed consent obtained from legal representatives
Exclusion Criteria:
- Patients under 18 years of age
- ICU length of stay less than 24 hours
- Patient or legal representative refused participation
- Hemoglobin level < 7 g/dL
- Arterial PaCO₂ > 70 mmHg
- Signs of circulatory failure
- Lactate > 4 mmol/L
- Capillary refill time > 3 seconds
- PaCO₂ - Central venous CO₂ gradient > 8 mmHg (if applicable)
- Mean arterial pressure (MAP) < 65 mmHg
- Mottling score ≥ 2
- Body temperature > 38°C
- Arterial pH < 7.20
- Body mass index (BMI) > 40 kg/m²
- Carbon dioxide production (VCO₂) > 4 mL/kg
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
Mechanically Ventilated Adult ICU Patients
Adult patients (aged ≥18 years) who received invasive mechanical ventilation in a tertiary intensive care unit.
All participants were prospectively monitored with volumetric capnography and arterial blood gas analysis to evaluate physiological dead space.
No interventions were applied as part of the study.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
ICU Mortality
Time Frame: Up to ICU discharge day or 28 day
|
All-cause mortality during the intensive care unit (ICU) stay.
|
Up to ICU discharge day or 28 day
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
ICU Length of Stay
Time Frame: Through ICU stay, up to 28 days
|
Number of days each patient spent in the ICU.
|
Through ICU stay, up to 28 days
|
|
Mechanical Ventilation Duration
Time Frame: From initiation of invasive mechanical ventilation to extubation or death or, up to 28 days
|
Total number of days under invasive mechanical ventilation.
|
From initiation of invasive mechanical ventilation to extubation or death or, up to 28 days
|
|
Change in Physiological Dead Space Over Time
Time Frame: Daily measurements for up to 3 days in the ICU
|
Temporal variation of physiological dead space calculated by Enghoff's modification of Bohr's equation (PaCO₂ - EtCO₂) / PaCO₂.
|
Daily measurements for up to 3 days in the ICU
|
|
Relationship Between Physiological Dead Space and Oxygenation
Time Frame: Daily during ICU stay (up to 3 days)
|
Correlation between dead space and oxygenation indices including PaO₂/FiO₂ ratio.
|
Daily during ICU stay (up to 3 days)
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Mehtap Pehlivanlar Kucuk, MD, Assoc. Prof., Karadeniz Technical University, Faculty of Medicine
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2024/154
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Critical Illness
-
Duke UniversityEunice Kennedy Shriver National Institute of Child Health and Human Development...Not yet recruitingDecision Making | Neonatal Critical Illness | Pediatric Critical IllnessUnited States
-
Duke UniversityNational Institute of Neurological Disorders and Stroke (NINDS); National Institutes...CompletedNeonatal Critical Illness | Pediatric Critical IllnessUnited States
-
Istituto Clinico HumanitasRecruitingCritical Illness Myopathy | Critical Illness Polyneuropathy | Critical Illness PolyneuromyopathyItaly
-
Assistance Publique - Hôpitaux de ParisEuropean Society of Intensive Care Medicine; French Society for Intensive Care and other collaboratorsRecruitingCritical Illness | Intensive Care Patients | Critical Illness Requiring Intensive Care - Sepsis | Critical Illness Requiring Intensive Care - Acute Brain Injury | Critical Illness Requiring Intensive Care - Major Surgery | Critical Illness Requiring Intensive Care - PolytraumaFrance
-
Boston Children's HospitalCompleted
-
McMaster UniversityLondon Health Sciences Centre; McMaster Children's Hospital; Canadian Critical...CompletedPediatric Critical IllnessCanada
-
Karolinska InstitutetNot yet recruitingPediatric Critical IllnessSweden
-
Sándor BeniczkyUniversity of Aarhus; Danish Council for Independent Research; Søster og Verner...CompletedCritical Illness Myopathy | Myopathy Critical IllnessDenmark
-
Istanbul Medeniyet UniversityRecruiting
-
St Helens & Knowsley Teaching Hospitals NHS TrustManchester University NHS Foundation TrustCompleted